US Patent Litigations are now available. Check here

Law FirmOpposition Filing Analysis

The comprehensive analysis of Elkington And Fife opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Elkington And Fife

Patent NumberTitleApplicantOpposition DateOpposition Company
EP4065119Methods Of Treating Pulmonary Arterial HypertensionACTELION PHARMACEUTICALSJun 4, 2025GENERICS UK
EP4014976Aprocitentan For Use In The Treatment Of Hypertension And Related Diseases In Combination With Angiotensin Converting Enzyme Inhibitor (Ace) Or Angiotensin Receptor Blocker (Arb)IDORSIA PHARMACEUTICALSMay 29, 2025ELKINGTON AND FIFE
EP3815684Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin TherapyAMARIN PHARMACEUTICALS IRELANDMay 9, 2025ELKINGTON AND FIFE
EP4088701Tampon ApplicatorONTEX GROUPMay 7, 2025THE PROCTER & GAMBLE
EP4165569System, Method, And Apparatus For Data Collection And AggregationMARS INCORPORATEDMay 7, 2025SOCIETE DES PRODUITS NESTLE
EP4005406Aerosol-Generating Article Having Mouthpiece With Upstream CavityPHILIP MORRISMay 2, 2025IMPERIAL TOBACCO
EP3799909Nasal Delivery DevicesOPTINOSEApr 10, 2025ELKINGTON AND FIFE
EP3897646Pharmaceutical Composition For The Treatment Of Pulmonary Arterial HypertensionACTELION PHARMACEUTICALSFeb 21, 2025GENERICS UK
EP4041186An Anhydrous Pharmaceutical Composition For Maintenance Treatment Of PsoriasisLEO PHARMAFeb 21, 2025GENERICS UK
EP4005555Methods For Ensuring Resuspension Of Paliperidone Palmitate FormulationsJANSSEN PHARMACEUTICAFeb 14, 2025ELKINGTON AND FIFE